Topics

Articles

Regulation enables better coordination of where opioids are going

DEA and distributors will share controlled-substance distribution data

Agency tries to get a handle on cross-border trade

FDA warns CanaRx, a Canadian “pharmacy” serving the US market

Issues include apparently diverted opioids and mislabeled medications

McKesson gets called out by FDA for alleged DSCSA violations

Will restricting use of rebates in federal programs carry over to commercial insurance?

Trump Administration gears up its drug-pricing campaign

Senate and House committees begin the legislative process for addressing drug pricing

Want Congressional bipartisanship? Talk about cutting drug prices!

Nov. 27, 2018, was to be a red-letter day in the 10-year program to implement an end-to-end pharma traceability system. Did industry meet the deadline?

DSCSA compliance: Industry is still in the trenches

Programs provide copay and other financial assistance

New PAP programs for HIV, migraine, bladder cancer and an enzyme deficiency

$360-million settlement involved assistance funneled through a charity

Actelion Pharmaceuticals settles with DoJ over patient copay improprieties

HFAP builds out from its hospital-accreditation business

There’s a new certification process for compounding pharmacies

More-complete information is desirable on some applications

Legal and Regulatory